Todd P. Kelsey Sells 1,000 Shares of Plexus Corp. (NASDAQ:PLXS) Stock

Plexus Corp. (NASDAQ:PLXS) CEO Todd P. Kelsey sold 1,000 shares of the business’s stock in a transaction dated Monday, April 29th. The stock was sold at an average price of $102.10, for a total transaction of $102,100.00. Following the sale, the chief executive officer now owns 113,810 shares in the company, valued at $11,620,001. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Plexus Stock Performance

Shares of PLXS opened at $103.39 on Friday. The stock has a 50 day moving average price of $95.10 and a 200 day moving average price of $98.62. The company has a quick ratio of 0.64, a current ratio of 1.51 and a debt-to-equity ratio of 0.15. The company has a market capitalization of $2.85 billion, a price-to-earnings ratio of 28.56 and a beta of 1.00. Plexus Corp. has a 52-week low of $83.84 and a 52-week high of $114.06.

Plexus (NASDAQ:PLXS) last announced its quarterly earnings results on Wednesday, April 24th. The technology company reported $0.94 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.87 by $0.07. The firm had revenue of $966.90 million during the quarter, compared to the consensus estimate of $950.75 million. Plexus had a return on equity of 10.77% and a net margin of 2.54%. The firm’s quarterly revenue was down 9.7% compared to the same quarter last year. During the same period in the prior year, the company posted $1.45 earnings per share. Research analysts predict that Plexus Corp. will post 3.61 EPS for the current fiscal year.

Hedge Funds Weigh In On Plexus

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Qube Research & Technologies Ltd boosted its holdings in Plexus by 93.7% in the third quarter. Qube Research & Technologies Ltd now owns 22,691 shares of the technology company’s stock valued at $2,110,000 after purchasing an additional 10,975 shares in the last quarter. Avior Wealth Management LLC lifted its stake in Plexus by 115.2% in the fourth quarter. Avior Wealth Management LLC now owns 2,118 shares of the technology company’s stock valued at $229,000 after buying an additional 1,134 shares during the last quarter. Vanguard Group Inc. lifted its stake in Plexus by 1.4% in the third quarter. Vanguard Group Inc. now owns 3,453,940 shares of the technology company’s stock valued at $321,147,000 after buying an additional 47,762 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. purchased a new stake in Plexus in the third quarter valued at approximately $715,000. Finally, First Eagle Investment Management LLC purchased a new stake in Plexus in the third quarter valued at approximately $5,865,000. 94.45% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on PLXS. Needham & Company LLC boosted their price target on shares of Plexus from $107.00 to $114.00 and gave the stock a “buy” rating in a research note on Friday, April 26th. Stifel Nicolaus boosted their price objective on Plexus from $90.00 to $95.00 and gave the stock a “hold” rating in a research report on Friday, April 26th. TheStreet downgraded Plexus from a “b” rating to a “c+” rating in a research report on Tuesday, February 13th. Sidoti downgraded Plexus from a “buy” rating to a “neutral” rating and set a $112.00 price objective for the company. in a research report on Tuesday, January 9th. Finally, Benchmark reissued a “buy” rating and set a $110.00 price objective on shares of Plexus in a research report on Wednesday, January 17th. Three analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat.com, Plexus presently has an average rating of “Hold” and an average target price of $107.75.

Plexus Company Profile

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.